title: A new conjugate vaccine against pneumococcal disease.
abstract: Streptococcus pneumoniae (pneumococcus) is a major cause of morbidity and mortality, particularly among infants and children. Pneumococcal 7-valent conjugate vaccine (PNCRM7) is the first conjugate vaccine known to prevent most invasive pneumococcal disease in infants and children. PNCRM7, which has a favorable safety profile, provides protection against invasive disease caused by antibiotic-resistant strains of S. pneumoniae, and the vaccine has demonstrated a significant impact on otitis media recurrence. Routine immunization with this vaccine should substantially reduce morbidity and mortality and improve the quality of life for infants, children, and their families.
authors.affiliation: Holy Rosary Medical Center, Ontario, Ore., USA.
authors.forename: M
authors.initials: M
authors.lastname: Wilson-Adkins
authors.forename: C
authors.initials: C
authors.lastname: Adkins
mesh_terms: D000328:Adult; D000368:Aged; D002675:Child, Preschool; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D022401:Meningococcal Vaccines / Q000008:administration & dosage / Q000494:pharmacology; D010353:Patient Education as Topic; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000494:pharmacology; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D018074:Vaccines, Conjugate
chemical_list: D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate